HEALTHJul 21 · 12:18 UTCMARKETWATCHJaimy Lee

Novo Nordisk sues Eli Lilly over ads comparing GLP-1 medications

Novo Nordisk is suing Eli Lilly over advertisements comparing GLP-1 medications. The drugmaker claims Lilly’s ads exclude the most up-to-date clinical information about its drugs.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

Novo NordiskorganizationEli LillyorganizationGLP-1 medicationstopicclinical informationtopic

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

BUSINESSJul 21 · 11:35 UTC
Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising
HEALTHJul 21 · 11:35 UTC
STAT+: Novo Nordisk sues Eli Lilly over GLP-1 drug ads it calls ‘deceptive’
BUSINESSJul 21 · 12:00 UTC
Novo Nordisk is suing Eli Lilly over ads it says mislead consumers on weight loss drug efficacy
HEALTHJul 16 · 01:05 UTC
Lawsuit filed by AG Ellison against e-cigarette manufacturer Loon
HEALTHMay 8 · 13:37 UTC
STAT+: The biotech news you need to read today